ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Preclinical

Pentadecapeptide BPC

Pentadecapeptide BPC

Also known as: BPC Variant, Stable BPC, BPC-157 Analog

Overview

Key Facts

Primary Goal: A stabilized variant of the BPC pentadecapeptide family, designed to improve bioavailability and extend activity

A stabilized variant of the BPC pentadecapeptide family, designed to improve bioavailability and extend activity. Shares the core healing mechanisms of BPC-157 with modifications aimed at enhanced oral stability. Half-Life 4-6 hours (estimated) Typical Dose 250–500 mcg Frequency 1-2x daily Cycle Length 4-12 weeks

Dosing Information

Half-Life

4-6 hours (estimated)

Typical Dose

250–500 mcg

Frequency

1-2x daily

Cycle Length

4-12 weeks

Administration Routes:

subcutaneousoral

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Preclinical

Preclinical data supports similar healing profiles to BPC-157 with potentially improved pharmacokinetics for oral dosing. Limited published literature compared to BPC-157; most data derives from comparative analog studies.

Frequently Asked Questions

Common questions about Pentadecapeptide BPC

UK-Specific Information

Exclusive data points and guidance for UK residents using Pentadecapeptide BPC

UK Lab Testing

US Lab Testing

Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With